Insider Trading Alert - SGEN, GEVO And QTM Traded By Insiders
Yesterday, Nov. 5, 2015, 68 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $5.04 to $15,303,456.72.
Highlighted Stocks Traded by Insiders:
Seattle Genetics (SGEN) - FREE Research Report
Gryska David W, who is Director at Seattle Genetics, sold 10,000 shares at $43.57 on Nov. 5, 2015. Following this transaction, the Director owned 23,950 shares meaning that the stake was reduced by 29.46% with the 10,000-share transaction.
The shares most recently traded at $42.13, down $1.44, or 3.43% since the insider transaction. Historical insider transactions for Seattle Genetics go as follows:
- 4-Week # shares sold: 17,074
- 12-Week # shares sold: 17,074
- 24-Week # shares sold: 17,074
The average volume for Seattle Genetics has been 1.1 million shares per day over the past 30 days. Seattle Genetics has a market cap of $6.2 billion and is part of the health care sector and drugs industry. Shares are up 37.82% year-to-date as of the close of trading on Thursday.
Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. Currently, there are 4 analysts who rate Seattle Genetics a buy, no analysts rate it a sell, and 5 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on SGEN - FREE
rates Seattle Genetics as a
. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Get the full
Seattle Genetics Ratings Report
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Gevo (GEVO) - FREE Research Report
Willis Mike, who is Cfo at Gevo, sold 48 shares at $1.98 on Nov. 5, 2015. Following this transaction, the Cfo owned 20,755 shares meaning that the stake was reduced by 0.23% with the 48-share transaction.
The shares most recently traded at $1.85, down $0.13, or 7.03% since the insider transaction. Historical insider transactions for Gevo go as follows:
- 4-Week # shares bought: 181,484
- 4-Week # shares sold: 965
- 12-Week # shares bought: 181,484
- 12-Week # shares sold: 2,682
- 24-Week # shares bought: 181,484
- 24-Week # shares sold: 316,417
The average volume for Gevo has been 461,200 shares per day over the past 30 days. Gevo has a market cap of $32.5 million and is part of the basic materials sector and chemicals industry. Shares are down 60% year-to-date as of the close of trading on Thursday.
Gevo, Inc., a renewable chemicals and biofuels company, focuses on the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The company operates in two segments, Gevo, Inc.; and Gevo Development/Agri-Energy. Currently, there is 1 analyst who rates Gevo a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on GEVO - FREE
rates Gevo as a
. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and generally disappointing historical performance in the stock itself. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Quantum (QTM) - FREE Research Report
Fuller Dale L, who is Director at Quantum, bought 10,000 shares at $0.94 on Nov. 5, 2015. Following this transaction, the Director owned 233,890 shares meaning that the stake was boosted by 4.47% with the 10,000-share transaction.
The shares most recently traded at $1.02, up $0.08, or 7.84% since the insider transaction. Historical insider transactions for Quantum go as follows:
- 4-Week # shares bought: 95,000
- 4-Week # shares sold: 170,000
- 12-Week # shares bought: 95,000
- 12-Week # shares sold: 170,000
- 24-Week # shares bought: 113,181
- 24-Week # shares sold: 170,000
The average volume for Quantum has been 1.8 million shares per day over the past 30 days. Quantum has a market cap of $244.4 million and is part of the technology sector and computer hardware industry. Shares are down 40.34% year-to-date as of the close of trading on Thursday.
Quantum Corporation provides scale-out storage, archive, and data protection solutions for small businesses to major enterprises in the Americas, Europe, and the Asia Pacific. The company has a P/E ratio of 14.7. Currently, there are 4 analysts who rate Quantum a buy, no analysts rate it a sell, and none rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on QTM - FREE
rates Quantum as a
. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and feeble growth in its earnings per share. Get the full
from
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.